Eric Jarlet
3 Papers
Eric Jarlet is an academic researcher. The author has contributed to research in topics: Insulin resistance & Medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Guillaume Treiber,Ania Flaus Furmaniuk,Alice Guilleux,Samir Medjane,Oriane Bonfanti,Stéphane Schneebeli,Céline Bernard,Nathalie Le-Moullec,Faouzi Bakiri,Maryse Pholsena,Olivier Rollot,Camille Vatier,Eric Jarlet,Isabelle Jéru,Olivier Lascols,Françoise Darcel,Bhoopendrasing Domun,Adrien Venault,Sophie Venault,Marie-Line Jacquemont,Bérénice Doray,Jean-Christophe Maiza,M. Cogne,Corinne Vigouroux,Estelle Nobecourt,Estelle Nobecourt +25 more
TL;DR: In this article, the level of expression of the LMNA 'Reunionese' variant determines the severity of both lipoatrophy and metabolic complications, leading to death in four cases.
16
Dengue clinical features and predictors of severity in the diabetic patient: a retrospective cohort study on Reunion island, 2019
Antoine Bertolotti,J. Maïza,Eric Jarlet,M. Cogne,E. Doussiet,Eric Magny,Olivier Maillard,Estelle Nobecourt,Patrick Gérardin +8 more
TL;DR: In this paper , a hospital-based cohort study was conducted to identify the factors characterizing dengue and those able to predict dengUE severity in the diabetic patient, including loss of appetite, altered mental status, high neutrophil to platelet ratios (>14.7), low haematocrit (<= 38%), upper-range serum creatinine (>100 micromol/l) and high urea to creatINine ratio (>50) were indicative of denguce severity in diabetic patients.
Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Réunion Randomized Controlled Trial
Florent Besnier,Victorine Lenclume,Patrick Gérardin,Adrian Fianu,Jérémy Martinez,N. Naty,S. Porcherat,Karim Boussaïd,Stéphane Schneebeli,Eric Jarlet,Sarah Hatia,Georges Dalleau,Chantal Verkindt,Jean-Frédéric Brun,Marie-Paule Gonthier,François Favier +15 more
TL;DR: The LIPOXmax intervention did not show a superiority in reducing FM in overweight or obese women but is associated with higher MFO and better glucose control improvements, and other studies are required before proposing LipOXmax training for the prevention of T2DM in overweight women.